LEXmedical: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
LEXmedical
Largest movements
- Receivables within one year +€25,996
up €25,996 (+5.6%), from €468,255 to €494,251
- Cash -€11,245
down €11,245 (-21.8%), from €51,676 to €40,431
mainly Receivables within one year (-€25,996) and Trade debts (-€4,863)
- Deferred charges and accrued income -€7,168
down €7,168 (-26.5%), from €27,048 to €19,880
- Profit (loss) carried forward +€11,858
up €11,858 (+2.3%), from €520,965 to €532,823
- Gross operating margin +€24,025
up €24,025 (+79.4%), from -€30,262 to -€6,237
- Financial income -€7,105
down €7,105 (-26.8%), from €26,561 to €19,456
- Other operating charges -€5,554
down €5,554 (-90.1%), from €6,164 to €610
- Taxes +€661
up €661, from €0 to €661
From the 31-12-2024 result to the 31-12-2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 31-12-2024 and 31-12-2025 balance sheets and the 31-12-2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 31-12-2024 | 31-12-2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €546,979 | €554,561 | +€7,583 | +1.4% |
| Current assets | 29/58 | €546,979 | €554,561 | +€7,583 | +1.4% |
| Stocks and contracts in progress | 3 | €0 | - | = | |
| Stocks | 30/36 | €0 | - | = | |
| Amounts receivable within one year | 40/41 | €468,255 | €494,251 | +€25,996 | +5.6% |
| Other amounts receivable | 41 | €468,255 | €494,251 | +€25,996 | +5.6% |
| Cash at bank and in hand | 54/58 | €51,676 | €40,431 | -€11,245 | -21.8% |
| Deferred charges and accrued income | 490/1 | €27,048 | €19,880 | -€7,168 | -26.5% |
| Total equity and liabilities | 10/49 | €546,979 | €554,561 | +€7,583 | +1.4% |
| Equity | 10/15 | €541,425 | €553,283 | +€11,858 | +2.2% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €1,860 | €1,860 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Profit (loss) carried forward | 14 | €520,965 | €532,823 | +€11,858 | +2.3% |
| Amounts payable | 17/49 | €5,554 | €1,278 | -€4,276 | -77.0% |
| Amounts payable within one year | 42/48 | €5,536 | €1,278 | -€4,258 | -76.9% |
| Trade debts | 44 | €5,536 | €673 | -€4,863 | -87.8% |
| Suppliers | 440/4 | €5,536 | €673 | -€4,863 | -87.8% |
| Taxes, remuneration and social security | 45 | €0 | €605 | +€605 | |
| Taxes | 450/3 | €0 | €605 | +€605 | |
| Accrued charges and deferred income | 492/3 | €18 | €0 | -€18 | -100% |
| Other operating charges | 640/8 | €6,164 | €610 | -€5,554 | -90.1% |
| Gross operating margin | 9900 | -€30,262 | -€6,237 | +€24,025 | +79.4% |
| Operating profit (loss) | 9901 | -€36,426 | -€6,847 | +€29,579 | +81.2% |
| Financial income | 75/76B | €26,561 | €19,456 | -€7,105 | -26.8% |
| Recurring financial income | 75 | €26,561 | €19,456 | -€7,105 | -26.8% |
| Financial charges | 65/66B | €163 | €90 | -€73 | -44.9% |
| Recurring financial charges | 65 | €163 | €90 | -€73 | -44.9% |
| Profit (loss) for the period before taxes | 9903 | -€10,028 | €12,519 | +€22,547 | |
| Income taxes | 67/77 | €0 | €661 | +€661 | |
| Profit (loss) for the period | 9904 | -€10,028 | €11,858 | +€21,887 | |
| Profit (loss) for the period to be appropriated | 9905 | -€10,028 | €11,858 | +€21,887 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 31 October 2026 via checked.be.